SCHEMBL3856424

SCHEMBL3856424

CC(C)COC(=O)CNC(=O)C1=C(O)c2cc(-c3ccccc3)ccc2C2(CCCC2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SPR P35270 2/20 0.35
EGLN1 Q9GZT9 7/20 0.35
HDAC1 Q13547 1/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPK14 Q16539 1/20 0.33
MAPK1 P28482 1/20 0.32
ITGB3 P05106 1/20 0.32
ITGAV P06756 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628517 0.86 PTPRC (0.41) SPREGLN1HDAC1MAPK1
SCHEMBL3861436 0.86 SPR (0.48) SPREGLN1MEN1KMT2AMAPK1
SCHEMBL12720457 0.85 EGLN1 (0.39) SPREGLN1HPGDMAPK14
SCHEMBL1625405 0.85 EGLN1 (0.47) EGLN1HPGDSMN1; SMN2
SCHEMBL3865775 0.78 HTT (0.41) SPREGLN1MAPTMEN1KMT2A
SCHEMBL3864870 0.74 SPR (0.39) SPREGLN1MEN1KMT2A
SCHEMBL1627204 0.73 SPR (0.46) SPREGLN1HDAC1MAPTRAB9A
SCHEMBL3840046 0.73 SPR (0.39) SPREGLN1MAPTKMT2AHPGD
SCHEMBL3837300 0.73 SPR (0.39) SPREGLN1MEN1KMT2ATP53
SCHEMBL3855928 0.72 HTT (0.34) SPREGLN1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2111399-A2 NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF Amgen Inc. (US) 2009-10-28 EP disclosed
WO-2008076427-A2 NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF AMGEN INC. (US) 2008-06-26 WO disclosed